Cooperative Agreement 72061221CA00010

The Department of Health and Human Services' Centers for Disease Control and Prevention (CDC) awarded a $25,300,000 Cooperative Agreement under the Global AIDS program (CFDA 93.067) to Ciheb Initiative LIMITED in Malawi. The award, titled "ACCELERATING MALAWI'S PEPFAR LABORATORY LOGISTICS AND INFRASTRUCTURE FOR QUALITY 2.0 (AMPLIFY 2.0)", will support comprehensive efforts to combat HIV/AIDS in Malawi through the President's Emergency Plan for AIDS Relief (PEPFAR). The 5-year...

This federal Project Grant award of $709,872 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to develop and pilot test a couple-based intervention to address perinatal depression and improve adherence to prevention of mother-to-child transmission (PMTCT) of HIV in Malawi. The key objectives are to: 1) develop a couple-based intervention using problem-solving therapy and content on couple...

The U.S. Centers for Disease Control and Prevention (CDC) has awarded a $10,151,871 Cooperative Agreement under the Global AIDS program (CFDA 93.067) to the University of California, San Francisco (UCSF) to lead the Alliance for Country-Led Control of the HIV Epidemic by Leveraging Efficient Resource Allocation to Achieve Equity (ACCELERATE) consortium. This 4-year award, effective September 30, 2024, aims to promote sustainable, data-driven, and equitable HIV/AIDS programs in Kenya, Uganda,...

This $15,221,142 Cooperative Agreement award, issued by the Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067), aims to develop, implement, and sustain high-quality comprehensive facility and community-based HIV 95-95-95 cascade activities for children, adolescents, and adults in Cameroon. The five-year project, implemented by the Association Camerounaise Pour LE Marketing Social (ACMS), seeks to achieve the UNAIDS 95-95-95 goals and contribute to...

This federal Cooperative Agreement award, funded by the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas program (CFDA 98.001), aims to increase the utilization of quality HIV prevention and treatment services in Tanzania through community-led monitoring activities. The $2.1 million award, with a performance period from January 1, 2025 to December 31, 2029, will be implemented by the National Council of People Living with HIV/AIDS (NACOPHA)...

The National Institute of Mental Health (NIMH) awarded a Project Grant (CFDA 93.242 - Mental Health Research Grants) totaling $707,796 to the Regents of the University of California, San Francisco (UCSF) to build on the success of the "Malkia Klabu" (MK) loyalty program and evaluate strategies for scaling the program's HIV prevention services for adolescent girls and young women (AGYW) in sub-Saharan Africa. The key products and services to be delivered under this grant include: 1)...

This Project Grant from the U.S. Department of State Bureau of African Affairs provided $120,179.59 to Ciheb Zambia LIMITED for community-led monitoring to improve the quality of HIV care in Zambia through client feedback. The grant was awarded on April 1, 2021 with a completion date of January 31, 2022. Under the President's Emergency Plan for AIDS Relief (PEPFAR) Programs (CFDA 19.029), the grantee and three sub-awardees—Ndekeleni Development Foundation, Youth Development Organisation, and...

This Cooperative Agreement award from the Centers for Disease Control and Prevention's (CDC) Global AIDS program (CFDA 93.067) provides $1,065,324 to the President's Office Regional Administration and Local Government (PORALG) in Tanzania. The project will accelerate the implementation of health policy strategies for HIV/AIDS treatment services over a 5-year period from September 30, 2024 to September 30, 2029. The funding will support technical assistance, service delivery, and...

This $7,410,542 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067) supports the "INGANJI RWANDA: EVIDENCE-BASED HIV PREVENTION AND CARE FOR KEY AND PRIORITY POPULATIONS" project led by the Center for Family Health Research (CFHR) in Rwanda. The project aims to optimize access to and use of evidence-based HIV prevention, testing, and treatment interventions among key and priority populations in Rwanda,...

This Cooperative Agreement, awarded by the U.S. Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067), provides $11,097,080 to Global Health Systems Solutions (GHSS) to build laboratory capacity and improve quality of HIV testing services in the Democratic Republic of the Congo (DRC). The key objectives are to: 1) scale up quality assurance and improvement for HIV rapid testing and TB testing; 2) increase coverage and timeliness of viral load, early...